All hyaluronic acid (HA) fillers contain the same molecule but behave dramatically differently based on cross-linking technology, particle size, and concentration. These formulation differences determine appropriate placement sites, longevity, and behavior in tissue. Understanding product characteristics helps you evaluate whether recommended fillers match your treatment goals.
Important Notice: This content provides general information about FDA-approved dermal fillers. Individual results vary based on injection technique, anatomy, and product selection. Always consult with qualified providers for personalized recommendations.
Hyaluronic Acid Properties: Why Formulation Matters
Hyaluronic acid is a naturally occurring sugar molecule found throughout the body, particularly in skin and joints. Its unique property: each molecule can hold up to 1,000 times its weight in water.
Unmodified HA degrades within 24-48 hours when injected. Chemical cross-linking creates bridges between HA molecules, stabilizing the structure and dramatically extending persistence.
Cross-linking technology varies by manufacturer. BDDE (1,4-butanediol diglycidyl ether) is the most common cross-linker used by Juvederm, Restylane, and others. The degree of cross-linking affects stiffness, longevity, and tissue integration.
G-prime (elastic modulus) measures filler stiffness. Higher G-prime fillers resist deformation better, suiting areas requiring structural support. Lower G-prime fillers flow more smoothly, integrating naturally in areas of movement.
Cohesivity describes how well filler particles hold together. Highly cohesive products maintain shape when manipulated. Less cohesive products spread more easily, suiting different applications.
Particle size influences behavior. Larger particles provide more lift but may be visible in thin skin. Smaller particles create smooth results but provide less structural support.
These properties intersect to create products suited for specific indications. Understanding the terminology helps decode marketing claims.
Juvederm Family: Vycross Technology Products
Allergan’s Juvederm line uses Vycross cross-linking technology, creating products with smooth, malleable characteristics.
Juvederm Voluma XC is designed for deep injection to restore cheek volume. High G-prime provides structural lift. FDA approved for up to 2 years duration. The firm gel lifts and projects effectively but can look unnatural if overfilled.
Juvederm Vollure XC (formerly Volift) targets moderate to severe facial wrinkles and nasolabial folds. Medium G-prime balances support with natural movement. FDA duration claim is 18 months. Versatile for multiple mid-face applications.
Juvederm Volbella XC is formulated for lips and perioral lines. Low G-prime creates soft, natural lip results. FDA duration claim is 12 months. The smooth formulation minimizes lumpiness in thin lip tissue.
Juvederm Ultra and Ultra Plus predate Vycross technology but remain available. Higher cohesivity than Vycross products. Commonly used for lips and general volume.
The Vycross advantage is longer duration with less product volume. Cross-linking efficiency allows more effect with less material. This can reduce swelling and create more natural results.
Restylane Family: NASHA and XpresHAn Technology
Galderma’s Restylane line includes both older NASHA technology and newer XpresHAn products.
NASHA (Non-Animal Stabilized Hyaluronic Acid) products include original Restylane, Restylane-L (with lidocaine), and Restylane Lyft. These products have granular particle structure rather than smooth gel consistency.
Restylane Lyft (formerly Perlane) provides firm support for cheek augmentation and nasolabial folds. Higher particle concentration creates significant lift. FDA approved for cheeks and hands.
Restylane Defyne uses XpresHAn technology for flexible support. The cross-linking allows movement without breaking down. Suited for areas requiring dynamic expression maintenance, like nasolabial folds in expressive faces.
Restylane Refyne provides even more flexibility than Defyne, designed for moderate wrinkles and folds where natural movement is paramount.
Restylane Kysse is formulated specifically for lips with XpresHAn technology. The flexible structure maintains natural lip movement while providing enhancement. Color-matching pigment claims to provide natural appearance.
Restylane Contour launched for cheek contouring with properties between Lyft’s firmness and Defyne’s flexibility.
The NASHA versus XpresHAn distinction matters clinically. NASHA products may be better for static areas wanting firm support. XpresHAn suits areas of movement.
RHA Collection: Dynamic Cross-Linking
The RHA (Resilient Hyaluronic Acid) collection from Revance represents newer technology designed specifically for areas of facial movement.
RHA technology uses longer HA chains with fewer cross-links than traditional fillers. This mimics natural HA behavior more closely, maintaining effect through repeated movement.
RHA 2, RHA 3, and RHA 4 offer progressively firmer formulations for different applications. RHA 2 treats moderate dynamic wrinkles. RHA 3 addresses deeper folds. RHA 4 provides the most lift for deeper volume needs.
Dynamic folds are the primary indication. Nasolabial folds, marionette lines, and perioral areas that move significantly with expression may benefit from RHA’s flexibility.
Longevity claims suggest RHA maintains effect well despite movement that might break down less flexible products. Real-world experience is still accumulating given the product’s relative newness.
Pricing positions RHA as premium product. Whether the dynamic properties justify cost premium depends on individual treatment areas and movement patterns.
Specialty Products: Lips, Tear Troughs, and Unique Indications
Certain applications require specific product characteristics.
Lip-specific products include Volbella, Restylane Kysse, and others formulated for the unique demands of lip tissue. Lips move constantly, have thin skin, and swell significantly after treatment. Low G-prime, high cohesivity formulations minimize lumpiness and tyndall effect.
Tear trough treatment requires extreme care. Only certain products are appropriate for this thin-skinned, vascular area. Restylane and Belotero have been commonly used. Thick, firm fillers in tear troughs create visible lumps and bluish tyndall discoloration.
Belotero Balance integrates smoothly into superficial tissue. Its cohesive polydensified matrix technology creates homogeneous gel that distributes evenly. This suits fine lines and superficial injection where other products would create visible ridges.
Under-eye specific products like Restylane Eyelight (not available in all markets) are formulated specifically for periorbital areas where standard fillers perform poorly.
Temple hollowing often uses Voluma or Restylane Lyft for deep structural support in this area prone to age-related volume loss.
Chin and jawline augmentation typically employs firm, high G-prime fillers. Voluma, Restylane Lyft, and specialized products like Juvederm Volux provide the structure needed for facial contouring.
Longevity Factors: Why Duration Claims Vary
FDA duration claims derive from clinical trials but individual results vary substantially.
Area treated affects longevity. High-movement areas (lips, perioral) metabolize filler faster than static areas (temples, cheeks). Lip filler typically lasts 6-9 months despite 12-month claims. Cheek filler often persists beyond labeled duration.
Individual metabolism matters significantly. Some patients metabolize HA rapidly regardless of product. Others maintain results longer than expected. No reliable predictor exists for individual response.
Product amount injected affects perception of duration. More product appears to last longer partly because it takes longer to fully resolve.
Cross-linking technology influences actual molecular longevity. Vycross and similar advanced technologies demonstrate improved resistance to enzymatic degradation.
Injection depth affects duration. Deep placement in structural positions may persist longer than superficial injection in mobile tissue.
Previous treatment in an area may affect duration. Some evidence suggests repeated treatment builds collagen that supports filler and maintains results.
Product Selection: Matching Characteristics to Goals
Appropriate product selection requires matching filler properties to treatment goals and anatomy.
For structural support (cheeks, chin, jawline): Choose high G-prime products like Voluma, Restylane Lyft, or equivalent. These resist deformation and provide meaningful lift.
For dynamic areas (nasolabial folds, perioral): Consider flexible products like Restylane Defyne, RHA products, or Vollure. These maintain natural movement while providing correction.
For lips: Use lip-specific products like Volbella, Kysse, or similar. Low G-prime prevents lumpiness. Smooth consistency integrates with delicate lip tissue.
For fine lines: Choose highly cohesive, smooth products like Belotero that won’t create visible ridges with superficial placement.
For tear troughs: Use only products specifically appropriate for this area, injected by experienced providers. Many fillers are inappropriate here.
Provider preference legitimately influences selection. An experienced injector achieves excellent results with their preferred products. Product choice matters less than injection technique and appropriate volume.
Reminder: Filler selection involves tradeoffs. The “best” product depends on your specific treatment area, goals, and anatomy. Marketing claims highlight advantages without contextualizing limitations. Experienced providers select products based on clinical properties, not promotional messaging.
Sources:
- HA filler technology and cross-linking: Published dermatologic surgery literature on filler chemistry
- Product-specific information: FDA labeling, manufacturer product guides
- G-prime and rheological properties: Aesthetic medicine rheology studies
- Duration studies: Published clinical trials, real-world outcome data
- Indication-specific recommendations: Consensus guidelines from aesthetic medicine societies